SCHEMBL3166181

SCHEMBL3166181

CC(=O)NCCNc1cc(NCCNC(=O)c2ccc(OC(F)(F)F)cc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 7/20 0.54
ADORA3 P0DMS8 1/20 0.52
GCGR P47871 9/20 0.47
GIPR P48546 4/20 0.47
CYP3A4 P08684 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2C9 P11712 1/20 0.45
KCNH2 Q12809 1/20 0.45
CHRNA7 P36544 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
FABP2 P12104 1/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171511 0.90 ADORA3 (0.51) TRPV1ADORA3CYP3A4ALDH1A1
SCHEMBL3170716 0.88 MAPT (0.53) ADORA3SMN1; SMN2MEN1NPC1RAB9A
SCHEMBL3175921 0.88 TRPV1 (0.51) TRPV1ADORA3GCGRGIPRCYP3A4
SCHEMBL3163102 0.87 MLYCD (0.46) TRPV1ADORA3CYP3A4SMN1; SMN2ALDH1A1
SCHEMBL3163297 0.85 NPC1 (0.55) ADORA3GCGRSMN1; SMN2ALDH1A1MEN1
SCHEMBL3170553 0.85 TP53 (0.53) ADORA3SMN1; SMN2MEN1NPC1RAB9A
SCHEMBL3163156 0.85 RAB9A (0.48) ADORA3SMN1; SMN2MEN1NPC1RAB9A
SCHEMBL3172697 0.84 NPC1 (0.47) ADORA3CYP3A4SMN1; SMN2ALDH1A1MEN1
SCHEMBL3175775 0.84 ADORA3 (0.48) ADORA3CYP3A4SMN1; SMN2ALDH1A1MEN1
SCHEMBL3176983 0.83 ADORA3 (0.57) ADORA3CYP3A4SMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed